Review Article
Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics
Table 3
SPION formulation for the delivery and tracking/imaging siRNA in cancer cells.
| S. no. SPION preparation | Coating | Targeting ligands | Imaging of internalized SPION | Cell line | Target | siRNA sequence | REF |
| (1) Coprecipitation | Chitosan, PEG, and PEI | CTX peptide | MRI Flow cytometry of Dy547-labelled siRNA | C6 rat glioma cells | GFP expression | 5′GAACUUCAGGGUCAGCUUGCUU3′ sense and 5′GCAAGCUGACCCUGAAGUUCUU3′ antisense | [37] | (2) Thermal decomposition | Oleic acid, PEI, and PEG | CTX peptide | MRI ferrozine-based assay | C6 cells | GFP | 5′GAACUUCAGGGUCAGCUUGCUU3′ sense and 5′GCAAGCUGACCCUGAAGUUCUU3′ antisense, | [38] | (3) Dextran coated iron oxide colloid crosslinked with epichlorohydrin, and treated with ammonia | Dextran | MPAP peptide | MRI optical imaging of Cy5.5-labelled SPIONs | LS174T and 9L | GFP | 5′-GCA AGC TGA CCC TGA AGT TC-3′ | [39] | (4) Thermal decomposition | PEG, and PPI G5 | LHRH peptide | MRI FAM-labeled siRNA complexes analyzed by fluorescence and confocal microscopes | A549 and SKOV-3 | BCL2 and β2-microglobulin | GGA TTG TGG CCT TCT TTG AG sense, CCA AAC TGA GCA GAG TCT TC antisense and ACC CCC ACTGAA AAA GAT GA sense, ATC TTC AAA CCT CCATGA TG antisense. | [40] |
|
|